drugset

drugset / Trial / NCT02512653

Biological Standarization of Cupressus Arizonica Allergen Extract to Determine the Biological Activity in Histamine Equivalent Units (HEP)

NCT02512653 ↗

Phase 2 Completed 33 enrolled Laboratorios Leti, S.L.

NaSingle-groupOpen-labelDiagnostic

Summary

Biological Standardization of Cupressus arizonica Allergen Extract.

Timeline

Start: 2015-11
Primary completion: 2015-12
Completion: 2016-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cupressus arizonica	Unknown	—	—

Indications